Healthcare providers can begin CIZ1B ordering setup through a provider onboarding process. Learn who can order CIZ1B, how setup works, and what happens next.

Lung cancer screening rates remain dangerously low, with fewer than one in five eligible adults getting screened. New national studies show how many lives could be saved through expanded screening and more accessible tools such as the CIZ1B biomarker blood test. This article breaks down the latest data and why early detection solutions are urgently needed.

While smoking remains the leading cause of lung cancer, tens of thousands of people who have never smoked are diagnosed each year. Learn about other risk factors—like radon, air pollution, and genetics—and how early detection can save lives.